fda tirzepatide compound approval Compounders protest as removes off shortage list FDA Says Compounded Tirzepatide Must

Younger individuals (children and adolescents) and older adults might require special considerations regarding dosages and potential side effects

Gradual escalation over 16 to 20 weeks is the standard clinical protocol precisely because it minimizes GI symptoms while still reaching a therapeutic dose

Benemae Pharmaceuticals benaglutide injection (Feisumei) was the first innovator approved for obesity in July 2023 in China followed by Novo Nordisks diabetes therapy semaglutide (Wegovy) in June 2024

A 20mg/mL vial contains twice as much medication in the same volume

Once reconstituted with bacteriostatic water, refrigerated storage at 2-8C maintains potency for approximately 28-30 days based on pharmaceutical stability data, though research-grade formulations may differ depending on buffer composition

The SURMOUNT-5 head to head trial confirmed this pattern